We are live on ! Find out more

279 hedge funds and large institutions have $4.83B invested in Axalta in 2022 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 105 increasing their positions, 100 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

636% more call options, than puts

Call options by funds: $32.6M | Put options by funds: $4.44M

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

5% more repeat investments, than reductions

Existing positions increased: 105 | Existing positions reduced: 100

0.72% more ownership

Funds ownership: 103.15%103.87% (+0.72%)

5% less capital invested

Capital invested by funds: $5.06B → $4.83B (-$234M)

7% less funds holding

Funds holding: 301279 (-22)

35% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 52

Holders
279
Holders Change
-22
Holders Change %
-7.31%
% of All Funds
4.79%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.09%
New
34
Increased
105
Reduced
100
Closed
52
Calls
$32.6M
Puts
$4.44M
Net Calls
+$28.2M
Net Calls Change
+$17.5M

AXTA Hedge Fund Activity: Q3 2022 in Review

279 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Axalta (AXTA) for Q3 2022, worth a combined $4.83B — down 4.6% from $5.06B a quarter earlier.

Sellers outnumbered buyers: 52 funds closed out of AXTA and 34 opened new positions — a net loss of 18 holders — while 100 trimmed existing stakes and 105 added.

The largest buyer was Boston Partners, adding an estimated $46.6M. The largest seller was Marshall Wace, cutting an estimated $63.6M.

  • 279 institutional investors held Axalta (AXTA) as of Q3 2022, down from 301 in Q2 2022.
  • Funds reported $4.83B of Axalta stock for Q3 2022, down 4.6% quarter-over-quarter.
  • 34 funds opened new Axalta positions in Q3 2022 and 52 closed out, a net change of -18 holders.
  • The largest Axalta buyer in Q3 2022 was Boston Partners, an estimated $46.6M added.
  • The largest Axalta seller in Q3 2022 was Marshall Wace, an estimated $63.6M sold.

Based on aggregated 13F filings for Q3 2022.